Drug Type Biosimilar, Hormone |
Synonyms Insulin degludec Biosimilar (Jilin Huisheng Biological Pharmaceutical Co., Ltd.), 德谷胰岛素生物类似药(Jilin Huisheng Biological Pharmaceutical Co., Ltd.), 惠优达 + [1] |
Target |
Mechanism INSR agonists(Insulin receptor agonists) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Inactive Organization- |
Drug Highest PhaseApproved |
First Approval Date CN (05 Aug 2024), |
Regulation- |
Indication | Country/Location | Organization | Date |
---|---|---|---|
Diabetes Mellitus, Type 2 | CN | 05 Aug 2024 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Diabetes Mellitus | NDA/BLA | CN | 15 Jul 2022 |